Begin main content

Saxagliptin + Metformin (Komboglyze) for Type 2 Diabetes Mellitus

Last Updated: August 23, 2013
Result type: Reports
Project Number: SR0348
Product Line: Common Drug Review

Generic Name: Saxagliptin + metformin

Brand Name: Komboglyze

Manufacturer: AstraZeneca Canada Inc.

Indications: Diabetes Mellitus, Type 2

Submission Type: New

Project Status: Complete

Date Recommendation Issued: June 20, 2014

Recommendation Type: List with criteria/condition